Answers are grounded in this paper and cite their sources.
A novel series of indolyl oxoacetamide-quinazolinone hybrid analogues (9aa–9df) were designed, synthesized, and evaluated for their in vitro pancreatic lipase (PL) inhibitory potential that may lead to efficient anti-obesity agents.
No takes yet. Share an insight, caveat, or question.
Auti et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: